About: Management Considerations for the Surgical Treatment of Colorectal Cancer During the Global Covid-19 Pandemic

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Management Considerations for the Surgical Treatment of Colorectal Cancer During the Global Covid-19 Pandemic Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Management Considerations for the Surgical Treatment of Colorectal Cancer During the Global Covid-19 Pandemic
Creator	O'leary, Michael Fong, Yuman Choong, Kevin Fakih, Marwan Kaiser, Andreas Thornblade, Lucas
Source	Medline; PMC
abstract	OBJECTIVE: The COVID-19 pandemic requires to conscientiously weigh “timely surgical intervention” for colorectal cancer against efforts to conserve hospital resources and protect patients and health care providers. SUMMARY BACKGROUND DATA: Professional societies provided ad-hoc guidance at the outset of the COVID-19 pandemic on deferral of surgical and perioperative interventions, but these lack specific parameters to determine the optimal timing of surgery. METHODS: Using the GRADE system, published evidence was analyzed to generate weighted statements for stage, site, acuity of presentation, and hospital setting to specify when surgery should be pursued, the time and duration of oncologically acceptable delays, and when to utilize nonsurgical modalities to bridge the waiting period. RESULTS: Colorectal cancer surgeries—prioritized as emergency, urgent with imminent emergency or oncologically urgent, or elective—were matched against the phases of the pandemic. Surgery in COVID-19-positive patients must be avoided. Emergent and imminent emergent cases should mostly proceed unless resources are exhausted. Standard practices allow for postponement of elective cases and deferral to nonsurgical modalities of stage II/III rectal and metastatic colorectal cancer. Oncologically urgent cases may be delayed for 6(–12) weeks without jeopardizing oncological outcomes. Outside established principles, administration of nonsurgical modalities is not justified and increases the vulnerability of patients. CONCLUSIONS: The COVID-19 pandemic has stressed already limited health care resources and forced rationing, triage, and prioritization of care in general, specifically of surgical interventions. Established guidelines allow for modifications of optimal timing and type of surgery for colorectal cancer during an unrelated pandemic.
has issue date	2020-05-22(xsd:dateTime)
bibo:doi	10.1097/sla.0000000000004029
bibo:pmid	32675510
has license	no-cc
sha1sum (hex)	90b8397277da51be561b4b41751419ecc5303855
schema:url	https://doi.org/10.1097/sla.0000000000004029
resource representing a document's title	Management Considerations for the Surgical Treatment of Colorectal Cancer During the Global Covid-19 Pandemic
has PubMed Central identifier	PMC7373490
has PubMed identifier	32675510
schema:publication	Ann Surg
resource representing a document's body	covid:90b8397277da51be561b4b41751419ecc5303855#body_text
is schema:about of	named entity 'stressed' named entity 'avoided' named entity 'published' named entity 'colorectal cancer' named entity 'perioperative' named entity 'administration' named entity 'timing' named entity 'rectal' named entity 'GRADE' named entity 'Methods' named entity 'Colorectal Cancer' named entity 'VULNERABILITY' named entity 'DELAYED' named entity 'COVID-19 PANDEMIC' named entity 'DURATION' named entity 'WAITING' named entity 'SPECIFIC' named entity 'EVIDENCE' named entity 'CONSERVE' named entity 'OUTSIDE' named entity 'PERIOPERATIVE' named entity 'COVID-19' named entity 'CASES' named entity 'GUIDANCE' named entity 'SURGERY' named entity 'MATCHED' named entity 'STAGE' named entity 'PARAMETERS' named entity 'DATA' named entity 'Emergent' named entity 'emergency' named entity 'surgery' named entity 'acceptable' named entity 'cases' named entity 'general' named entity 'proceed' named entity 'deferral' named entity 'care' named entity 'health care' named entity 'exhausted' named entity 'Results' named entity 'postponement' named entity 'metastatic' named entity 'surgical intervention' named entity 'metastatic colorectal cancer' named entity 'Colorectal cancer' named entity 'COVID-19 pandemic' named entity 'stage II' named entity 'Colorectal Cancer' named entity 'Established' named entity 'colorectal cancer' named entity 'neoadjuvant chemotherapy' named entity 'metastatic cancer' named entity 'FOLFIRI' named entity 'COVID-19' named entity 'FOLFOX' named entity 'oncological' named entity 'adenoma' named entity 'colon cancer' named entity 'High-risk' named entity 'FOLFOX' named entity 'pCR' named entity 'comorbidities' named entity 'health care' named entity 'complete response' named entity 'stochastic process' named entity 'significant difference' named entity 'curative intent' named entity 'neoadjuvant chemotherapy' named entity 'infection' named entity 'time frame' named entity 'fluoropyrimidine' named entity 'neoadjuvant' named entity 'Subacute' named entity 'metastatic disease' named entity 'neoadjuvant'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software